20-Oct-2014 - Eli Lilly is set to close one of its Puerto Rican facilities as patent expirations and a shifting portfolio reduce its need for capacity.
15-Oct-2014 - Agilent Technologies is to exit its Nuclear Magnetic Resonance (NMR) business because it has not met growth and profit targets.
15-Oct-2014 - [View the story "Hej Sweden: in-Pharmatechnologist talks production strategy with AstraZeneca and Pfizer" on Storify]
14-Oct-2014 - Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers.
14-Oct-2014 - Gilead says its hepatitis C combination drug Harvoni will deliver significant healthcare savings in the long-term despite its $1,150 (€885) a pill price tag.
13-Oct-2014 - The pharmaceutical industry must change its ingredients and manufacturing methods to cash in on the enormous purchasing power of European Muslims, says an expert.
10-Oct-2014 - US academics have licensed a mobile clean room design from Xoma for a vaccine and medical countermeasure plant being built in Texas as part of an HHS-funded project.
09-Oct-2014 - The phrase “lean manufacturing” conjures up job cuts and not much more for many people, but managers can use the method to drastically simplify HPAPI (highly potent active pharmaceutical ingredients) production, says an expert.
09-Oct-2014 - Drugmakers will “inevitably” shift from batch to continuous production of tablets and, according to Freeman Technology, a quality by design (QbD) approach is a fundamental requirement.
08-Oct-2014 - Consolidation in the pharma industry is driving the second-hand processing equipment market but despite attempts to regulate the industry, a glut of online vendors means illegal drugmakers can buy such systems.
07-Oct-2014 - Lonza has launched an API-making platform that uses chemical microreaction technology for continuous processing.
06-Oct-2014 - Including explosion protection in initial facility plans can save money in the long-term, according to Rembe, especially as drugmakers continue to work with more volatile ingredients.
06-Oct-2014 - Hospira has received a US FDA Warning Letter at an Australian injectables facility months after workers asked the firm not turn the site into “the new Rocky Mount.”
02-Oct-2014 - A laser diffraction imaging tool could be used by quality controllers to help measure particle size in a suspension according to Malvern Instruments.
02-Oct-2014 - Boehringer Ingelheim is investing more than €100m ($126m) at its Dortmund, Germany site to expand production capacity for its Respimat inhaler, which is the third time in the past four years that the company has made a capacity-expanding investment at the site.
29-Sep-2014 - in-Pharmatechnologist.com is live from Nuremberg to bring you the best from TechnoPharm and POWTECH 2014, Europe's largest processing and powder shows.
25-Sep-2014 - The Medicines Manufacturing Industry Partnership (MMIP) between the ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association) and a number of companies aims to make the UK a more attractive destination for pharma manufacturing.
24-Sep-2014 - Hundreds of workers brought in to help fix manufacturing issues at a Boehringer Ingelheim facility will not be affected despite the firm looking to shave 600 jobs in a €450m ($580m) cost-cutting initiative.
24-Sep-2014 - The market opportunity for each Indian drugmakers granted a license to manufacture Gilead’s hepatitis C drug Sovaldi could be worth over $600m, an analyst has calculated.
23-Sep-2014 - Novartis has announced a second round of lay-offs at its manufacturing site in Suffern, New York ahead of the plant’s closure in 2016.
22-Sep-2014 - Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.
17-Sep-2014 - Merck Serono has struck a deal with Indian drugmaker Lupin to bring a number of drugs for cardiovascular and diabetes diseases to emerging markets.
17-Sep-2014 - Hospira has invested 15m AUD ($14m) in a Victoria injectables plant it says will continue to make drugs for export despite the economic downturn and strong Australian dollar.
16-Sep-2014 - Gilead has granted seven Indian drugmakers licenses to produce generic versions of its $1,000 a pill drug Sovaldi to increase access to hepatitis C medicines in 91 developing countries.
11-Sep-2014 - Industry groups BIO (Biotechnology Industry Association) and GPhA (Generic Pharmaceutical Association) are calling for outsourcing facilities to be held to the same standards as other, larger manufacturers.
The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert...
dispatches from technopharm
Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts...
Pre CPhI Special
The world is getting larger, at least it is in terms of the pharmaceutical industry, according to...
Pre CPhI Special
Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to...
The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid...
The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database...